Drug–drug interactions in nursing home residents: analysis from the COME-ON trial
Authors:
- 1 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 52 (1)
Abstract
Background: as a result of the high prevalence of polypharmacy in nursing homes (NHs), nursing home residents (NHRs) are exposed to numerous drug–drug interactions (DDIs) that can lead to adverse drug effects, and increased morbidity and mortality. Objectives: to evaluate (i) the prevalence of DDIs among NHRs and its evolution over time, and (ii) factors associated with a favourable evolution. Design: posthoc analysis of the COME-ON study, a cluster-randomised controlled trial aiming at reducing potentially inappropriate prescriptions in NHs, through the implementation of a complex intervention. Setting and subjects: 901 NHRs from 54 Belgian NHs. Methods: DDIs were identified using a validated list of 66 potentially clinically relevant DDIs in older adults. We defined a favourable evolution at 15 months as the resolution of at least one DDI present at baseline, without the introduction of any new DDI. Factors associated with a favourable evolution were analysed using multivariable logistic regression. Results: at baseline, 475 NHRs (52.7%) were exposed to at least 1 DDI and 225 NHRs (25.0%) to more than one DDI. Most common DDI was ‘Concomitant use of at least three central nervous system active drugs’. At 15 months, we observed a 6.3% absolute decrease in DDI prevalence in intervention group, and a 1.0% absolute increase in control group. The intervention, older age and private NH ownership were significantly associated with a favourable DDI evolution. Conclusion: a high prevalence of DDI in Belgian NHs was observed, but the COME-ON intervention was associated with a favourable evolution over time.Keywords
This publication has 22 references indexed in Scilit:
- Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homesTrials, 2017
- Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive ImpairmentThe Journal of Clinical Psychiatry, 2017
- A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot StudyDrugs & Aging, 2015
- Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trialImplementation Science, 2015
- Prevalence and Factors Associated With Polypharmacy in Long-Term Care Facilities: A Systematic ReviewJournal of the American Medical Directors Association, 2015
- Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substancesEuropean Neuropsychopharmacology, 2013
- Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkableExpert Opinion on Drug Safety, 2007
- The challenge of managing drug interactions in elderly peopleThe Lancet, 2007
- Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug ToxicityJAMA, 2003
- Psychotropic drug use in nursing homes - diagnostic indications and variations between institutionsEuropean Journal of Clinical Pharmacology, 2001